This inventor holds 1 USPTO granted patent. Top assignee: Everlight Chemical Industrial Corporation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations of Yu-Ting Su in Pharmaceutical Chemistry
Introduction
Yu-Ting Su is a notable inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on morphinan derivatives. His research focuses on the development of new pharmaceutical compositions that can potentially enhance therapeutic outcomes.
Latest Patents
Yu-Ting Su holds a patent for "Crystals of morphinan derivative, manufacturing method thereof, and pharmaceutical composition using the same." This invention pertains to an X-form crystal of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[N-methyl-trans-3-(3-furyl)acrylamido]morphinan hydrochloride. The patent details the manufacturing method of this crystal, which exhibits characteristic diffraction peaks at specific positions in a powder X-ray diffraction pattern. This innovative compound is expected to have significant applications in pharmaceutical formulations.
Career Highlights
Yu-Ting Su is associated with Everlight Chemical Industrial Corporation, where he continues to advance his research in pharmaceutical chemistry. His work has been instrumental in developing new compounds that can be utilized in various medical applications.
Collaborations
Yu-Ting Su collaborates with talented individuals in his field, including Yuan-Yi Wang and Yu-Kai Li. These collaborations enhance the research environment and contribute to the innovative outcomes of their projects.
Conclusion
Yu-Ting Su's contributions to pharmaceutical chemistry through his patent on morphinan derivatives exemplify the importance of innovation in the medical field. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile